tiprankstipranks
Diamedica Therapeutics (DMAC)
:DMAC
US Market

Diamedica Therapeutics (DMAC) Ownership - Who Owns Diamedica Therapeutics?

Compare
485 Followers

Diamedica Therapeutics (DMAC) Ownership Overview

33.75%3.38%2.93%59.94%
33.75% Insiders
2.93% ETFs
59.94% Public Companies and Individual Investors
The ownership structure of Diamedica Therapeutics (DMAC) stock is a mix of institutional, retail, and individual investors. , 33.75% is owned by Insiders, and 59.94% is owned by Public Companies and Individual Investors.
The ownership structure of Diamedica Therapeutics (DMAC) stock is a mix of institutional, retail, and individual investors. Approximately 6.31% of the company’s stock is owned by Institutional Investors, 33.75% is owned by Insiders, and 59.94% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 01, 2024
Thomas Von Koch
>10% Owner
xxxxxxxxxxxxx
$3000000
Jul 01, 2024
Jan Stahlberg
>10% Owner
xxxxxxxxxxxxx
$3000000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,526,435Insider12.92%34,761,276
5,221,608Insider12.21%32,843,914
2,205,795Insider5.20%13,874,451
1,194,009Institution2.79%7,510,317
1,000,931Institution2.34%6,295,856
527,114Insider1.23%3,315,547
422,055Insider0.99%2,654,726
278,602Insider0.65%1,752,407
274,713Institution0.64%1,727,945
114,730Institution0.27%721,652

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,000,931Institution2.34%6,295,856
274,713Institution0.64%1,727,945
114,730Institution0.27%721,652
24,554Institution0.06%154,445
15,764Institution0.04%99,156
13,251Institution0.03%83,349
1,836Institution<0.01%11,548
576Institution<0.01%3,623

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
747,198Institution1.75%4,057,285
446,811Institution1.04%2,426,184
55,496Institution0.13%349,070
3,243Institution<0.01%20,269

FAQ

Who Owns Diamedica Therapeutics (DMAC)?
Currently, no data Available
What percentage of Diamedica Therapeutics (DMAC) stock is held by institutional investors?
Currently, no data Available
What percentage of Diamedica Therapeutics (DMAC) stock is held by retail investors?
According to the latest TipRanks data, approximately 59.94% of Diamedica Therapeutics (DMAC) stock is held by retail investors.
    Who owns the most shares of Diamedica Therapeutics (DMAC)?
    Thomas Von Koch owns the most shares of Diamedica Therapeutics (DMAC).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis